According to legal filings, some Trulicity patients believe that Trulicity caused or contributed to these complications, and they allege that they were not properly warned
Tirzepatide weight loss Tirzepatide works by activating both glucagon-like peptide-1 (GLP-1 receptor agonists) and glucose-dependent insulinotropic polypeptide (GIP), hormones that control appetite and influence eating habits, enhancing insulin release and helping improve the amount of weight loss
3.2 In vivo evidence Liu et al
After this adjustment window, urinary frequency typically returns to baseline for the majority of patients, though individual experiences vary based on hydration habits and dose level
PMID: 30900410
Without getting too deep into the science, glucagon-like peptide-1, or GLP-1, is a hormone produced in the gut when food enters the stomach